FDA Clearance Tracker · P060002
FLAIR ENDOVASCULAR STENT GRAFT
Last checked: Nov 19, 2026Latest source record: Jul 23, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Jul 23, 2007
Approval withdrawn
Time to decision
552 days
Received Jan 17, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P060002
- Device name
- FLAIR ENDOVASCULAR STENT GRAFT
- Applicant
- Bard Peripheral Vascular
- Applicant location
- Tempe, AZ
- Received
- Jan 17, 2006
- Decided
- Jul 23, 2007
- Decision
- Approval withdrawn
- Supplements
- 36 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE FLAIR ENDOVASCULAR STENT GRAFT. THE DEVICE IS INDICATED FOR USE IN THE TREATMENT OF STENOSES AT THE VENOUS ANASTOMOSIS OF EPTFE OR OTHER SYNTHETIC ARTERIOVENOUS (AV) ACCESS GRAFTS.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PFV (System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Bard Peripheral Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
K262571 · Decided Aug 14, 2026 · 21 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K260012 · Decided Feb 4, 2026 · 30 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.